Form 4: Arcutis Biotherapeutics Executive Sells Shares
Insider Transaction (Form 4)
Patrick Burnett, See Remarks of Arcutis Biotherapeutics, Inc., sold 15,000 shares of common stock on August 11, 2026.
Summary
- Option exercise/conversion: acquired 8,300 Common Stock at $3.64 ($30,212) on August 11, 2026; holds 127,589 after (Direct).
- Open-market sale: disposed of 8,300 Common Stock at $26.52 ($220,129) on August 11, 2026; holds 119,289 after (Direct).
- Option exercise/conversion: acquired 6,700 Common Stock at $3.64 ($24,388) on August 12, 2026; holds 125,989 after (Direct).
- Open-market sale: disposed of 6,700 Common Stock at $26.08 ($174,767) on August 12, 2026; holds 119,289 after (Direct).
- Option exercise/conversion: disposed of 8,300 Stock Option (right to buy) on August 11, 2026; holds 135,450 after (Direct).
- Option exercise/conversion: disposed of 6,700 Stock Option (right to buy) on August 12, 2026; holds 128,750 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $394,897 of stock on the open market.
Insider Transactions
Patrick Burnett — Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Option exercise/conversion | Common Stock | 8,300 | $4 | $30.2K | 127,589 |
| 2026-08-11 | Open-market sale | Common Stock | 8,300 | $27 | $220.1K | 119,289 |
| 2026-08-12 | Option exercise/conversion | Common Stock | 6,700 | $4 | $24.4K | 125,989 |
| 2026-08-12 | Open-market sale | Common Stock | 6,700 | $26 | $174.8K | 119,289 |
| 2026-08-11 | Option exercise/conversion | Stock Option (right to buy) | 8,300 | — | — | 135,450 |
| 2026-08-12 | Option exercise/conversion | Stock Option (right to buy) | 6,700 | — | — | 128,750 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Option exercise/conversion (8,300 shares) |
| 2026-08-11 | Open-market sale (8,300 shares) |
| 2026-08-12 | Option exercise/conversion (6,700 shares) |
| 2026-08-12 | Open-market sale (6,700 shares) |
| 2026-08-11 | Option exercise/conversion (8,300 shares) |
| 2026-08-12 | Option exercise/conversion (6,700 shares) |
Keywords
insider transaction, Form 4, ARQT, Arcutis Biotherapeutics, Inc., bearish, Patrick Burnett
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.